Abstract
Background Diphtheria has been re-emerging around the world at alarming rates, raising concerns about emergency preparedness when global supplies of life-saving diphtheria antitoxin are insufficient. Outbreaks have occurred in areas with suboptimal coverage of the three-dose diphtheria tetanus and pertussis (DTP3) vaccine and regions experiencing conflict, but systematic studies assessing the association between these variables and the risk of diphtheria emergence are limited. This population-level study aimed to investigate the relationship between fatalities from armed conflict events, childhood DTP3 vaccination coverage, and the presence of reported diphtheria cases in countries in the World Health Organization’s (WHO) African region from 2017-2024.
Methods The analysis was conducted at the subnational geographic scale of administrative level 1 (ADM1) (N countries=35, N ADM1 regions=541) from March 2017 to March 2024. We first used a univariate logistic regression model to establish a crude relationship between the ADM1 diphtheria status from 2017-2024 and the population-adjusted cumulative conflict-related fatalities from 2013-2024. We then fit three competing generalized logistic models with random effects accounting for weekly repeated measures at the ADM1 and country levels to estimate the relationship between time-varying rates of conflict-related fatalities and diphtheria status, adjusting for diphtheria vaccine coverage estimates.
Results Results from the crude model indicate that higher ten-year cumulative rates of conflict-related fatalities are associated with a higher risk of reported diphtheria cases (OR = 1.41, 95% CI: 1.17-1.68). The results from the best-fitting repeated measures model indicate that higher rates of log-transformed conflict-related fatalities are associated with a 17.6-fold increase in diphtheria risk (OR = 17.6, 95% CI: 13.99-22.08), though risk varied widely by state and country. The best-fit model also associated lower estimates of diphtheria risk in areas with high (>80%) and low (<50%) vaccine coverage, though this is possibly due to underreporting of the true burden of disease in low-resource settings.
Conclusions This exploratory analysis indicates that a history of fatalities from armed conflict is a potentially helpful indicator of subnational diphtheria risk in countries in the WHO African region from 2017-2024. Further, it may be especially useful if estimates of population-level diphtheria immunity are limited.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available human data. Diphtheria case count data are publicly available and were originally located at the WHO African Region located here: https://www.afro.who.int/health-topics/disease-outbreaks/outbreaks-and-other-emergencies-updates Additional diphtheria case data were obtained from the Nigerian CDC situation reports found here: https://ncdc.gov.ng/ncdc.gov.ng/diseases/sitreps/?cat=18&name=An%20Update%20of%20Diphtheria%20Outbreak%20in%20Nigeria Data on fatalities from armed conflict events were obtained from the Armed Conflict Location and Event Database, which is publicly accessible here: https://acleddata.com/data/ And aggregated data on state-level childhood vaccination coverage estimates were obtained from the Demographic Health Surveys here: https://dhsprogram.com/data/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Author emails
T.osullivan{at}utah.edu
Lindsay.keegan{at}utah.edu
List of abbreviations
- WHO
- World Health Organization
- DAT
- diphtheria antitoxin
- VPD
- vaccine-preventable disease
- DTP3
- three-dose diphtheria tetanus pertussis
- ADM1, ADM0
- vaccine, administrative level 1, 0
- DHS
- Demographic Health Survey
- ACLED
- Armed Conflict Location and Event Data
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.